PLBD: protein-ligand binding database of thermodynamic and kinetic intrinsic parameters.


Journal

Database : the journal of biological databases and curation
ISSN: 1758-0463
Titre abrégé: Database (Oxford)
Pays: England
ID NLM: 101517697

Informations de publication

Date de publication:
08 06 2023
Historique:
received: 31 01 2023
accepted: 15 05 2023
medline: 12 6 2023
pubmed: 8 6 2023
entrez: 8 6 2023
Statut: ppublish

Résumé

We introduce a protein-ligand binding database (PLBD) that presents thermodynamic and kinetic data of reversible protein interactions with small molecule compounds. The manually curated binding data are linked to protein-ligand crystal structures, enabling structure-thermodynamics correlations to be determined. The database contains over 5500 binding datasets of 556 sulfonamide compound interactions with the 12 catalytically active human carbonic anhydrase isozymes defined by fluorescent thermal shift assay, isothermal titration calorimetry, inhibition of enzymatic activity and surface plasmon resonance. In the PLBD, the intrinsic thermodynamic parameters of interactions are provided, which account for the binding-linked protonation reactions. In addition to the protein-ligand binding affinities, the database provides calorimetrically measured binding enthalpies, providing additional mechanistic understanding. The PLBD can be applied to investigations of protein-ligand recognition and could be integrated into small molecule drug design. Database URL https://plbd.org/.

Identifiants

pubmed: 37290059
pii: 7192311
doi: 10.1093/database/baad040
pmc: PMC10250011
pii:
doi:

Substances chimiques

Ligands 0
Carbonic Anhydrase Inhibitors 0
Carbonic Anhydrases EC 4.2.1.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Lietuvos Mokslo Taryba
ID : S-LLT-20-2

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press.

Références

Drug Discov Today. 2022 Aug;27(8):2076-2079
pubmed: 35577233
Biochemistry. 1990 Jul 24;29(29):6927-40
pubmed: 2204424
Eur Biophys J. 2021 May;50(3-4):661-670
pubmed: 33837826
Biophys J. 2020 Oct 20;119(8):1513-1524
pubmed: 32971003
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D668-72
pubmed: 16381955
J Appl Crystallogr. 2019 May 28;52(Pt 3):618-625
pubmed: 31236093
Nat Rev Drug Discov. 2016 Oct;15(10):679-98
pubmed: 27516170
Brief Bioinform. 2022 Jan 17;23(1):
pubmed: 34849575
J Mol Biol. 2008 Dec 26;384(4):1002-17
pubmed: 18930735
J Med Chem. 2018 Mar 22;61(6):2292-2302
pubmed: 29466001
J Biomol Screen. 2001 Dec;6(6):429-40
pubmed: 11788061
Drug Discov Today. 2006 Jul;11(13-14):580-94
pubmed: 16793526
Nucleic Acids Res. 2020 Jul 2;48(W1):W48-W53
pubmed: 32297936
Nucleic Acids Res. 2013 Jan;41(Database issue):D1096-103
pubmed: 23087378
Chem Rev. 2008 Mar;108(3):946-1051
pubmed: 18335973
Biochemistry. 2005 Apr 5;44(13):5258-66
pubmed: 15794662
Eur Biophys J. 2019 Mar;48(2):139-152
pubmed: 30535510
J Med Chem. 2014 Nov 26;57(22):9435-46
pubmed: 25358084
Bioinformatics. 2015 Feb 1;31(3):405-12
pubmed: 25301850
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
Nat Protoc. 2016 May;11(5):882-94
pubmed: 27055097
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
Nucleic Acids Res. 2015 Jan;43(Database issue):D465-9
pubmed: 25378330
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D522-6
pubmed: 16381925
Nucleic Acids Res. 2008 Jan;36(Database issue):D667-73
pubmed: 17933762
J Comput Aided Mol Des. 2015 Sep;29(9):867-83
pubmed: 26376645
Anal Biochem. 2017 Apr 1;522:61-72
pubmed: 28153585
Q Rev Biophys. 2018 Jan;51:e10
pubmed: 30912486
Biophys Chem. 2010 Nov;152(1-3):153-63
pubmed: 20943306
Nucleic Acids Res. 2016 Jan 4;44(D1):D1045-53
pubmed: 26481362
PLoS One. 2012;7(5):e36899
pubmed: 22655030
Mol Inform. 2015 Aug;34(8):568-76
pubmed: 27490502
MD Comput. 1998 May-Jun;15(3):162-6
pubmed: 9617087
Biophys J. 1996 Oct;71(4):2049-55
pubmed: 8889179

Auteurs

Darius Lingė (D)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Marius Gedgaudas (M)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Andrius Merkys (A)

Sector of Crystallography and Cheminformatics, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Vytautas Petrauskas (V)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Antanas Vaitkus (A)

Sector of Crystallography and Cheminformatics, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Algirdas Grybauskas (A)

Sector of Crystallography and Cheminformatics, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Vaida Paketurytė (V)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Asta Zubrienė (A)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Audrius Zakšauskas (A)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Aurelija Mickevičiūtė (A)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Joana Smirnovienė (J)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Lina Baranauskienė (L)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Edita Čapkauskaitė (E)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Virginija Dudutienė (V)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Ernestas Urniežius (E)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Aleksandras Konovalovas (A)

Department of Biochemistry and Molecular Biology, Institute of Biosciences, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Egidijus Kazlauskas (E)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Kirill Shubin (K)

Latvian Institute of Organic Synthesis, Aizkraukles Street 21, Riga LV-1006, Latvia.

Helgi B Schiöth (HB)

Functional Pharmacology and Neuroscience, Department of Surgical Sciences, Uppsala University, Kirurgiska Vetenskaper, Box 593, Uppsala 751 24, Sweden.

Wen-Yih Chen (WY)

Department of Chemical and Materials Engineering, National Central University, No. 300, Zhongda Rd., Zhongli Dist., Taoyuan City, Jhong-Li 320, Taiwan.

John E Ladbury (JE)

School of Molecular and Cellular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.

Saulius Gražulis (S)

Sector of Crystallography and Cheminformatics, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Daumantas Matulis (D)

Department of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Saulėtekio 7, Vilnius LT-10257, Lithuania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH